HA
VIE

HHLR Advisors’s Viela Bio, Inc. Common Stock VIE Stock Holding History

HHLR Advisors’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,382,414
Closed -$85.7M – 106
2020
Q4 		$85.7M Sell
2,382,414
-95,217
-4% -$3.34M 0.68% 26
2020
Q3 		$69.6M Sell
2,477,631
-338,237
-12% -$12M 0.53% 28
2020
Q2 		$122M Sell
2,815,868
-1,775,308
-39% -$80.4M 1.12% 20
2020
Q1 		$174M Hold
4,591,176
– – 2.35% 13
2019
Q4 		$125M Buy
+4,591,176
New +$116M 1.55% 18

HHLR Advisors's VIE Position: Q1 2021 in Review

HHLR Advisors sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 2,382,414 shares — an estimated $85.7M sold.

HHLR Advisors first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $174M in Q1 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

  • HHLR Advisors reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • HHLR Advisors sold 2,382,414 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $85.7M.
  • HHLR Advisors first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • HHLR Advisors's Viela Bio, Inc. Common Stock position peaked at $174M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on HHLR Advisors's 13F filing for Q1 2021, filed 17 May 2021.